
Blended research preparation of CJC-1295 No DAC and Ipamorelin supplied for in-vitro laboratory characterisation.
CJC-1295 + Ipamorelin is a blended laboratory preparation combining 10 mg of CJC-1295 No DAC (modified GRF 1-29) with 10 mg of Ipamorelin in a single sterile amber vial, giving researchers a consistent two-component reference material for comparative in-vitro work.
Every vial supplied by NXT GEN RESEARCH is manufactured to strict laboratory standards, HPLC-characterised and independently third-party tested for identity and purity.
Blended peptide preparations are referenced in laboratory literature in fields including:
All work described in the scientific literature is conducted in controlled in-vitro laboratory environments.
Every batch of CJC-1295 + Ipamorelin supplied by NXT GEN RESEARCH is HPLC-characterised and independently third-party tested for identity and purity, giving researchers consistent, well-documented material for their laboratory workflow.
Lyophilised material: -20 °C. In solution: 2–8 °C; laboratory practice commonly references a working life of up to 28 days from first entry when stored correctly.
This product is supplied exclusively for scientific and laboratory research. It is not intended for human or veterinary consumption, administration, diagnosis, treatment or therapeutic use.

Synthetic pentadecapeptide fragment for in-vitro laboratory characterisation.

Synthetic thymosin β4 fragment for in-vitro laboratory characterisation.

Copper tripeptide-1 for in-vitro biochemical characterisation.

Mitochondrial-derived peptide supplied for in-vitro laboratory research.

I am over 18 years of age. I am a professional or student researcher.
Research grade compounds · Not for human or animal consumption